Animal Antibiotic and Antimicrobial Market: Trends, Opportunities and Competitive Analysis [2023-2028]

Animal Antibiotic and Antimicrobial Market Trends and Forecast

The future of the animal antibiotic and antimicrobial market looks promising with opportunities in the food-producing animal and companion animal segments. The global animal antibiotic and antimicrobial market is expected to reach an estimated $6.1 billion by 2028 with a CAGR of 4% from 2023 to 2028. The major drivers for this market are increasing demand for animal derived foods, growing cases of diseases among animals, and rising concern towards health of animals.

Animal Antibiotic and Antimicrobial Market by Product Type, Mode of Delivery, Animal Type, and Region

A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.

Animal Antibiotic and Antimicrobial Market by Segments

Animal Antibiotic and Antimicrobial Market by Segment

The study includes trends and forecast for the global animal antibiotic and antimicrobial market by product type, mode of delivery, animal type, and region, as follows:

Animal Antibiotic and Antimicrobial Market by Product Type [Value ($B) Shipment Analysis from 2017 to 2028]:

Tetracycline

Penicillin

Sulfonamide

Macrolide

Aminoglycoside

Lincosamide

Fluoroquinolone

Cephalosporin

Others

Animal Antibiotic and Antimicrobial Market by Mode of Delivery [Value ($B) Shipment Analysis from 2017 to 2028]:

Premixes

Oral Powder

Oral Solution

Injection

Others

Animal Antibiotic and Antimicrobial Market by Animal Type [Value ($B) Shipment Analysis from 2017 to 2028]:

Food-Producing Animals

Cattle

Pigs

Poultry

Sheep and Goats

Others

Companion Animals

Dogs

Cats

Horses

Others

Animal Antibiotic and Antimicrobial Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

North America

Europe

Asia Pacific

The Rest of the World

List of Animal Antibiotic and Antimicrobial Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, animal antibiotic and antimicrobial companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the animal antibiotic and antimicrobial companies profiled in this report include-

Boehringer Ingelheim

Zoetis

Elanco Animal Health

Merck

Phibro Animal Health

Animal Antibiotic and Antimicrobial Market Insights

Lucintel forecasts that tetracycline will remain the largest product type segment over the forecast period because it ensures maximum efficacy against pathogenic germs and is less expensive than other animal antibiotics present in the market.

Food producing animal is expected to remain the larger animal type segment due to the growing expenditure for veterinary treatment, rising spread of zoonotic diseases, and increasing need for nutritious animal feeding.

North America will remain the largest region due to growing livestock production and increasing expenditure for the development of medicines to treat animal diseases in the region.

Features of the Animal Antibiotic and Antimicrobial Market

Market Size Estimates: Animal antibiotic and antimicrobial market size estimation in terms of value ($B)

Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.

Segmentation Analysis: Animal antibiotic and antimicrobial market size by various segments, such as product type, mode of delivery, animal type, and region

Regional Analysis: Animal antibiotic and antimicrobial market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.

Growth Opportunities: Analysis on growth opportunities in different product types, modes of delivery, animal types, and regions for the animal antibiotic and antimicrobial market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape for the animal antibiotic and antimicrobial market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the animal antibiotic and antimicrobial market size?

Answer: The global animal antibiotic and antimicrobial market is expected to reach an estimated $6.1 billion by 2028.

Q2. What is the growth forecast for animal antibiotic and antimicrobial market?

Answer: The global animal antibiotic and antimicrobial market is expected to grow with a CAGR of 4% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the animal antibiotic and antimicrobial market?

Answer: The major drivers for this market are increasing demand for animal derived foods, growing cases of diseases among animals, and rising concern towards health of animals.

Q4. What are the major segments for animal antibiotic and antimicrobial market?

Answer: The future of the animal antibiotic and antimicrobial market looks promising with opportunities in the food-producing animal and companion animal segments.

Q5. Who are the key animal antibiotic and antimicrobial companies?

Answer: Some of the key animal antibiotic and antimicrobial companies are as follows:

Boehringer Ingelheim

Zoetis

Elanco Animal Health

Merck

Phibro Animal Health

Q6. Which animal antibiotic and antimicrobial segment will be the largest in future?

Answer: Lucintel forecasts that tetracycline will remain the largest product type segment over the forecast period because it ensures maximum efficacy against pathogenic germs and is less expensive than other animal antibiotics present in the market.

Q7. In animal antibiotic and antimicrobial market, which region is expected to be the largest in next five years?

Answer: North America will remain the largest region due to growing livestock production and increasing expenditure for the development of medicines to treat animal diseases in the region.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

• Q.1. What are some of the most promising, high-growth opportunities for the animal antibiotic and antimicrobial market by product type (tetracycline, penicillin, sulfonamide, macrolide, aminoglycoside, lincosamide, fluoroquinolone, cephalosporin, and others), mode of delivery (premixes, oral powder, oral solution, injection, and others), animal type (food-producing animals and companion animals), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?